Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies

Clinical trial NCT06298292 · UNKNOWN

Trial details

NCT number: NCT06298292
Sponsor: metaX Institut fuer Diatetik GmbH
Status: UNKNOWN
Study type: OBSERVATIONAL

Tyrosinemia, Type I Tyrosinemia, Type II Tyrosinemia, Type III Alkaptonuria Homocystine; Metabolic Disorder MSUD (Maple Syrup Urine Disease)

Start date: 2024-04-01
Primary completion: 2026-03-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.